Related Subjects:
Chronic Heart Failure |
Heart Failure and Pulmonary Oedema |
Loop Diuretics |
Entresto Sacubitril with Valsartan |
Ivabradine |
Furosemide |
Angiotensin Converting Enzyme Inhibitors |
Cardiac Resynchronisation Therapy (CRT) Pacemaker |
About : Always check the BNF link here
Mode of action
Indication/Dose
Sacubitril valsartan (Entresto) is recommended as an option for treating symptomatic chronic heart failure with reduced ejection fraction, only in adults:
Dose range:You must check with BNF or drug datasheet
Name Starting Dose Frequency Route Entresto (Sacubitril/Valsartan) 24/26 mg BD PO for 3-4 weeks then can increase Entresto (Sacubitril/Valsartan) 49/51 mg BD PO for 3-4 weeks then can increase Entresto (Sacubitril/Valsartan) 97/103 mg BD PO for 3-4 weeks then can increase Interactions
Cautions
Contraindications
Side effects
References
Revisions
MEDICAL DISCLAIMER:The contents are under continuing development and improvements and despite all efforts may contain errors of omission or fact. This is not to be used for the assessment, diagnosis or management of patients. It should not be regarded as medical advice by healthcare workers or laypeople. It is for educational purposes only. Please adhere to your local protocols. Use the BNF for drug information. If you are unwell please seek urgent healthcare advice. If you do not accept this then please do not use the website. Makindo Ltd |
Sacubitril with Valsartan
-
| About | Anaesthetics and Critical Care | Anatomy | Basic Science | Biochemistry | Cardiology | Cases | Clinical Cases | Crib | Dentistry | Dermatology | Differentials | Drugs | ENT | Electrocardiogram | Embryology | Emergency Medicine | Endocrinology | Ethics | Foundation Doctors | Gastroenterology | General Information | General Practice | Genetics | Geriatric Medicine | Guidelines | Haematology | Hepatology | Immunology | Infectious Disease | Infectious Diseases | Infographic | Investigations | Lists | Microbiology | Miscellaneous | Nephrology | Neuroanatomy | Neurology | Nutrition | OSCE | Obstetrics Gynaecology | Oncology | Ophthalmology | Oral Medicine | Paediatrics | Palliative | Pathology | Pharmacology | Physiology | Procedures | Psychiatry | Radiology | Research | Respiratory | Resuscitation | Rheumatology | Statistics | Stroke | Surgery | Surgical | Toxicology | Trauma and Orthopaedics | Twitter | Urology | Version Jan 2023